GeoVax Labs Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
2,417.60
883.00
428.10
828.90
1,075.30
963.20
Cost of Goods Sold (COGS) incl. D&A
-
69.00
-
-
-
-
Gross Income
-
813.90
-
-
-
-
SG&A Expense
4,628.20
3,551.50
3,093.90
4,073.50
3,221.70
3,506.10
EBIT
2,289.50
2,737.60
2,694.80
3,273.40
2,174.50
2,562.70
Pretax Income
2,284.90
2,733.60
2,689.30
3,271.70
2,170.20
2,560.10
Consolidated Net Income
2,284.90
2,733.60
2,689.30
3,271.70
2,170.20
2,560.10
Net Income
2,284.90
2,733.60
2,689.30
3,271.70
2,170.20
2,560.10
Net Income After Extraordinaries
2,284.90
2,733.60
2,689.30
3,271.70
2,170.20
2,560.10
Net Income Available to Common
2,284.90
2,733.60
2,689.30
3,271.70
2,170.20
2,560.10
EPS (Basic)
0.11
0.10
0.08
0.08
0.03
7.82
Basic Shares Outstanding
21,212.30
26,645.10
31,950.80
41,516.50
68,605.80
327.20
EPS (Diluted)
0.11
0.10
0.08
0.08
0.03
7.82
Diluted Shares Outstanding
21,212.30
26,645.10
31,950.80
41,516.50
68,605.80
327.20
EBITDA
2,210.60
2,668.60
2,665.80
3,244.60
2,146.40
2,542.90
Non-Operating Interest Income
4.50
4.10
5.50
1.70
4.30
5.20
About GeoVax Labs
View Profile
